The DOI matches its Crossref record; 303 of the 303 references it cites were found in a registry or an index.
Nanoparticles and targeted drug delivery in cancer therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–303 of 303
Magadala, P., & Amiji, M. M. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9065-0 · Cited by 87
PEGylated Liposomal Doxorubicin Targeted to α5β1-Expressing MDA-MB-231 Breast Cancer Cells
Shroff, K., & Kokkoli, E. (2012) · Langmuir · doi:10.1021/la204466g · Cited by 86
Jiang, W., Xie, H., Ghoorah, D., Shang, Y., Shi, H., Liu, F., Yang, X., & Xu, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037376 · Cited by 86
Pangburn, T. O., Georgiou, K., Bates, F. S., & Kokkoli, E. (2012) · Langmuir · doi:10.1021/la300874z · Cited by 85
Pinzón‐Daza, M., Garzón, R., Couraud, P., Romero, I., Weksler, B., Ghigo, D., Bosia, A., & Riganti, C. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02103.x · Cited by 84
Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA delivery
Asai, T., Tsuzuku, T., Takahashi, S., Okamoto, A., Dewa, T., Nango, M., Hyodo, K., Ishihara, H., Kikuchi, H., & Oku, N. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.01.107 · Cited by 84
Gray, B. P., Li, S., & Brown, K. C. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300498d · Cited by 84
Lectin-mediated drug delivery in the oral cavity
Smart, J. D. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.016 · Cited by 83
Chemical Aspects of Coumarin Compounds for the Prevention of Hepatocellular Carcinomas
Okamoto, T., Kobayashi, T., & Yoshida, S. (2005) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011053352622 · Cited by 83
Kluza, E., Jacobs, I., Hectors, S. J. C. G., Mayo, K. H., Griffioen, A. W., Strijkers, G. J., & Nicolay, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.032 · Cited by 82
Master, А. M., Qi, Y., Oleinick, N. L., & Gupta, A. S. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.09.012 · Cited by 79
Liu, Y., Mei, L., Yu, Q., Xu, C., Qiu, Y., Yang, Y., Shi, K., Zhang, Q., Gao, H., Zhang, Z., et al. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b04596 · Cited by 79
Micellar Hybrid Nanoparticles for Simultaneous Magnetofluorescent Imaging and Drug Delivery
Park, J., von Maltzahn, G., Ruoslahti, E. I., Bhatia, S. N., & Sailor, M. J. (2008) · Angewandte Chemie · doi:10.1002/ange.200801810 · Cited by 79
Tiwari, P. M., Eroğlu, E., Bawage, S. S., Vig, K., Miller, M. E., Pillai, S., Dennis, V. A., & Singh, S. R. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.07.032 · Cited by 77
Jadidi-Niaragh, F., Atyabi, F., Rastegari, A., Mollarazi, E., Kiani, M., Razavi, A., Yousefi, M., Kheshtchin, N., Hassannia, H., Hadjati, J., et al. (2016) · Tumor Biology · doi:10.1007/s13277-015-4732-0 · Cited by 77
Self-citationOcampo‐García, B., Ramı́rez, F. D. M., Ferro‐Flores, G., Rodriguez, L. M. D. L., Santos‐Cuevas, C., Morales-Ávila, E., de Murphy, C. A., Pedraza-López, M., Medina, L. A., & Camacho-López, M. A. (2010) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2010.07.007 · Cited by 76
Immunotherapeutic approaches for cancer therapy: An updated review
Kazemi, T., Younesi, V., Jadidi‐Niaragh, F., & Yousefi, M. (2015) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2015.1019669 · Cited by 76
Self-citationDoxorubicin-conjugated chimeric polypeptide nanoparticles that respond to mild hyperthermia
McDaniel, J. R., MacEwan, S. R., Dewhirst, M. W., & Chilkoti, A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.02.030 · Cited by 76
Siahmansouri, H., Somi, M. H., Babaloo, Z., Baradaran, B., Jadidi‐Niaragh, F., Atyabi, F., Mohammadi, H., Ahmadi, M., & Yousefi, M. (2016) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12593 · Cited by 76
Self-citationPolyethylene sebacate–doxorubicin nanoparticles for hepatic targeting
Guhagarkar, S. A., Gaikwad, R. V., Samad, A., Malshe, V. C., & Devarajan, P. V. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.09.012 · Cited by 75
Nanoparticle delivery of a peptide targeting EGFR signaling
Kim, S. K., & Huang, L. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.014 · Cited by 75
He, X., Liu, F., Liu, L., Duan, T., Zhang, H., & Wang, Z. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400456j · Cited by 71
Enhancement of antitumor properties of TRAIL by targeted delivery to the tumor neovasculature
Cao, L., Du, P., Jiang, S.-H., Jin, G., Huang, Q.-L., & Hua, Z. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0533 · Cited by 71
Kaufman, C. L., Williams, M., Ryle, L. M., Smith, T. L., Tanner, M., & Ho, C. (2003) · Transplantation · doi:10.1097/01.tp.0000090164.42732.47 · Cited by 70
Maiolino, S., Russo, A., Pagliara, V., Conte, C., Ungaro, F., Russo, G., & Quaglia, F. (2015) · Journal of Nanobiotechnology · doi:10.1186/s12951-015-0088-2 · Cited by 70
Morlieras, J., Dufort, S., Sancey, L., Truillet, C., Mignot, A., Rossetti, F., Dentamaro, M., Laurent, S., Elst, L. V., Müller, R. N., et al. (2013) · Bioconjugate Chemistry · doi:10.1021/bc4002097 · Cited by 69
Liu, B. R., Li, J.-F., Lu, S.-W., Lee, H.-J., Huang, Y., Shannon, K. B., & Aronstam, R. S. (2010) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2010.2637 · Cited by 69
Frasco, M. F., Almeida, G. M., Santos‐Silva, F., Pereira, M. D. C., & Coelho, M. A. N. (2014) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35286 · Cited by 69
Yuan, M., Qiu, Y., Zhang, L., Gao, H., & He, Q. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1040527 · Cited by 69
Chariou, P. L., Lee, K. L., Wen, A. M., Gulati, N. M., Stewart, P. L., & Steinmetz, N. F. (2015) · Bioconjugate Chemistry · doi:10.1021/bc500545z · Cited by 68
Gao, H., Zhang, Q., Yang, Y., Jiang, X., & He, Q. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.11.029 · Cited by 68
TP10, a delivery vector for decoy oligonucleotides targeting the Myc protein
Andaloussi, S. E., Johansson, H. J., Magnúsdóttir, A., Järver, P., Lundberg, P., & Langel, Ü. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.012 · Cited by 68
EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity
Sandoval, M. A., Sloat, B. R., Lansakara-P, D. S. P., Kumar, A., Rodriguez, B. L., Kiguchi, K., DiGiovanni, J., & Cui, Z. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.015 · Cited by 66
Cell‐penetrating chitosan/doxorubicin/TAT conjugates for efficient cancer therapy
Lee, J., Choi, Y., Suh, J. S., Kwon, Y. M., Yang, V. C.-M., Lee, S. J., Chung, C., & Park, Y. (2010) · International Journal of Cancer · doi:10.1002/ijc.25578 · Cited by 66
Lin, J., Zhou, Z., Li, Z., Zhang, C., Wang, X., Wang, K., Gao, G., Huang, P., & Cui, D. (2013) · Nanoscale Research Letters · doi:10.1186/1556-276x-8-170 · Cited by 66
Syu, W., Yu, H., Hsu, C., Rajan, Y. C., Hsu, Y., Chang, Y., Hsieh, W., Wang, C., & Lai, P. (2012) · Small · doi:10.1002/smll.201102695 · Cited by 66
Cryan, S., Devocelle, M. C., Moran, P. J., Hickey, A. J., & Kelly, J. G. (2005) · Molecular Pharmaceutics · doi:10.1021/mp050070i · Cited by 65
Peptide-Targeted Polyglutamic Acid Doxorubicin Conjugates for the Treatment of αvβ6-Positive Cancers
Guan, H., McGuire, M. J., Li, S., & Brown, K. C. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800154f · Cited by 65
Lipoprotein Nanoplatform for Targeted Delivery of Diagnostic and Therapeutic Agents
Glickson, J. D., Lund‐Katz, S., Zhou, R., Choi, H., Chen, I., Li, H., Corbin, I. R., Popov, A. V., Cao, W., Song, L., et al. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-85998-9_35 · Cited by 65
Ren, W.-H., Chang, J., Yan, C., Qian, X.-M., Long, L., He, B., Yuan, X.-B., Kang, C., Betbeder, D., Sheng, J., et al. (2010) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-010-4106-5 · Cited by 64
Hami, Z., Amini, M., Ghazi‐Khansari, M., Rezayat, S. M., & Gilani, K. (2014) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/2008-2231-22-30 · Cited by 63
Su, C., Li, H., Shi, Y., Wang, G., Liu, L., Zhao, L., & Su, R. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.08.026 · Cited by 62
Mannosylated semiconductor quantum dots for the labeling of macrophages
Higuchi, Y., Oka, M., Kawakami, S., & Hashida, M. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.10.007 · Cited by 62
Bioconjugated PLGA-4-arm-PEG branched polymeric nanoparticles as novel tumor targeting carriers
Ding, H. Y., Yong, K., Roy, I., Hu, R., Wu, F. P., Zhao, L., Law, W., Zhao, W., Ji, W., Liu, L., et al. (2011) · Nanotechnology · doi:10.1088/0957-4484/22/16/165101 · Cited by 62
Ragelle, H., Colombo, S., Pourcelle, V., Vanvarenberg, K., Vandermeulen, G., Bouzin, C., Marchand‐Brynaert, J., Féron, O., Foged, C., & Véronique Préat, A. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.05.274 · Cited by 61
Kim, J., Kim, Y., Bae, K. H., Park, T. G., Lee, J. H., & Park, K. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500737y · Cited by 61
Galactodendritic Phthalocyanine Targets Carbohydrate-Binding Proteins Enhancing Photodynamic Therapy
Pereira, P. M. R., Silva, S., Cavaleiro, J. A. S., Ribeiro, C., Tomé, J. P. C., & Fernandes, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095529 · Cited by 61
Zheng, C.-Y., Ma, C., Bai, E., Yang, K., & Xu, R. (2015) · PubMed Central · Cited by 60
“Alternative” endocytic mechanisms exploited by pathogens: New avenues for therapeutic delivery?☆
Medina‐Kauwe, L. K. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.009 · Cited by 58
Dendrimer-triglycine-EGF nanoparticles for tumor imaging and targeted nucleic acid and drug delivery
Yuan, Q., Lee, E., Yeudall, W. A., & Yang, H. (2010) · Oral Oncology · doi:10.1016/j.oraloncology.2010.07.001 · Cited by 58
Pandey, S., Mewada, A., Thakur, M., Shah, R., Oza, G., & Sharon, M. (2013) · Materials Science and Engineering C · doi:10.1016/j.msec.2013.05.007 · Cited by 57
Reynolds, L., Mulik, R. S., Wen, X., Dilip, A., & Corbin, I. R. (2014) · Nanomedicine · doi:10.2217/nnm.13.187 · Cited by 57
Li, J., Ma, F. K., Dang, Q., Liang, X., & Chen, X. (2014) · Frontiers of Materials Science · doi:10.1007/s11706-014-0262-8 · Cited by 57
Mehdizadeh, A., Pandesh, S., Shakeri‐Zadeh, A., Kamrava, S. K., Habibagahi, M., Farhadi, M. R., Pishghadam, M., Ahmadi, A., Arami, S., & Fedutik, Y. A. (2013) · Lasers in Medical Science · doi:10.1007/s10103-013-1414-2 · Cited by 56
Melemenidis, S., Jefferson, A., Ruparelia, N., Akhtar, A. M., Xie, J., Allen, P. D., Hamilton, A., Larkin, J. R., Pérez-Balderas, F., Smart, S., et al. (2015) · Theranostics · doi:10.7150/thno.10319 · Cited by 56
Chang, J., Yoon, I., Sun, P., Yi, E., Jheon, S., & Shim, C. (2014) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2014.07.005 · Cited by 55
Folate-targeting magnetic core–shell nanocarriers for selective drug release and imaging
Wang, H., Wang, S., Liao, Z., Zhao, P., Su, W., Niu, R., & Chang, J. K. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.04.009 · Cited by 55
Ghalamfarsa, G., Hojjat‐Farsangi, M., Mohammadnia‐Afrouzi, M., Anvari, E., Farhadi, S., Yousefi, M., & Jadidi‐Niaragh, F. (2016) · Journal of Immunotoxicology · doi:10.3109/1547691x.2016.1159264 · Cited by 54
Self-citationTemming, K., Meyer, D. L., Zabinski, R. F., Dijkers, E. C. F., Poelstra, K., Molema, G., & Kok, R. J. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060087z · Cited by 52
Genetically engineering transferrin to improve its in vitro ability to deliver cytotoxins
Yoon, D. J., Chu, D. S. H., Ng, C., et al. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.006 · Cited by 52
Varshosaz, J., Sadeghi‐Aliabadi, H., Ghasemi, S., & Behdadfar, B. (2013) · BioMed Research International · doi:10.1155/2013/680712 · Cited by 52
Integrins and extracellular matrix in mechanotransduction
Ramage, L. (2011) · Cell Health and Cytoskeleton · doi:10.2147/chc.s21829 · Cited by 52
Kopecka, J., Porto, S., Lusa, S., Gazzano, E., Salzano, G., Pinzón‐Daza, M. L., Giordano, A., Desiderio, V., Ghigo, D., Rosa, G. D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8012 · Cited by 52
Gupta, A., Gupta, R. K., & Gupta, G. (2009) · Journal of Scientific & Industrial Research · Cited by 50
Transferrin-Coated Gadolinium Nanoparticles as MRI Contrast Agent
Korkusuz, H., Ulbrich, K., Welzel, K., Koeberle, V., Watcharin, W., Bahr, U., Chernikov, V. P., Knobloch, T., Petersen, S., Huebner, F., et al. (2012) · Molecular Imaging and Biology · doi:10.1007/s11307-012-0579-6 · Cited by 49
Chen, B.-A., Bao, W., Liu, R., Wang, Y., Wang, F., Xia, G., Zhang, H., Li, X., & Yin, H. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s75090 · Cited by 49
Reynolds, J. L., Law, W., Mahajan, S. D., Aalinkeel, R., Nair, B. B., Sykes, D. E., Yong, K., Hui, R., Prasad, P. N., & Schwartz, S. A. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9379-7 · Cited by 49
Park, H., Tsutsumi, H., & Mihara, H. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.094 · Cited by 47
Kopecka, J., Porto, S., Lusa, S., Gazzano, E., Salzano, G., Giordano, A., Desiderio, V., Ghigo, D., Caraglia, M., Rosa, G. D., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5058 · Cited by 47
Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatment
Gormley, A. J., Malugin, A., Ray, A., Robinson, R., & Ghandehari, H. (2011) · Journal of drug targeting · doi:10.3109/1061186x.2011.623701 · Cited by 46
Intracellular Delivery of Oligonucleotide Conjugates and Dendrimer Complexes
Juliano, R. L. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1348.011 · Cited by 46
Xia, H., Gu, G., Hu, Q., Liu, Z., Jiang, M., Kang, T., Miao, D., Song, Q., Yao, L., Tu, Y., et al. (2013) · Bioconjugate Chemistry · doi:10.1021/bc300520t · Cited by 45
Wen, X., Wang, K., Zhao, Z., Zhang, Y., Sun, T., Zhang, F., Wu, J. H., Fu, Y., Du, Y., Zhang, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106652 · Cited by 44
Oehlke, J., Wallukat, G., Wolf, Y., Ehrlich, A., Wiesner, B., Berger, H., & Bienert, M. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04236.x · Cited by 44
Development of targeted therapy with paclitaxel incorporated into EGF-conjugated nanoparticles.
Shimada, T., Ueda, M., Jinno, H., Chiba, N., Wada, M., Watanabe, J., Ishihara, K., & Kitagawa, Y. (2009) · PubMed · Cited by 43
Zhang, X., Koh, C. G., Yu, B., et al. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9864-8 · Cited by 41
Zhang, X., Zhang, C.-G., Zhu, Q., Zhou, Y., Liu, Y., Chen, W., Yang, S.-D., Zhou, X., Zhu, A.-J., Jin, Y., et al. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s59799 · Cited by 41
D’souza, A. A., Jain, P. P., Galdhar, C. N., Samad, A., Degani, M. S., & Devarajan, P. V. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9474-6 · Cited by 40
Corbin, I. R., & Zheng, G. (2007) · Nanomedicine · doi:10.2217/17435889.2.3.375 · Cited by 40
Selectins Ligand Decorated Drug Carriers for Activated Endothelial Cell Targeting
Banquy, X., Leclair, G., Rabanel, J., Argaw, A., Bouchard, J., Hildgen, P., & Giasson, S. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800257m · Cited by 40
Targeted Fluoromagnetic Nanoparticles for Imaging of Breast Cancer MCF-7 Cells
Majd, M. H., Barar, J., Asgari, D., Valizadeh, H., Rashidi, M., Kafil, Shahbazi, J., & Omidi, Y. (2013) · Europe PMC (PubMed Central) · doi:10.5681/apb.2013.031 · Cited by 40
Yoon, D. J., Kwan, B. H., Chao, F. C., Nicolaides, T. P., Phillips, J. J., Lam, G. Y., Mason, A. B., Weiss, W. A., & Kamei, D. T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4311 · Cited by 39
Erlotinib in the treatment of non-small cell lung cancer: current status and future developments.
Gridelli, C., Maione, P., Bareschino, M. A., Schettino, C., Sacco, P. C., Ambrosio, R., Barbato, V., Falanga, M., & Rossi, A. (2010) · PubMed · Cited by 38
Ren, H., Gao, C., Zhou, L., Liu, M., Xie, C., & Lu, W. (2014) · Drug Delivery · doi:10.3109/10717544.2014.896057 · Cited by 35
Optimized multimodal nanoplatforms for targeting αvβ3 integrins
Bolley, J., Lalatonne, Y., Haddad, O., Letourneur, D., Soussan, M., Pérard‐Viret, J., & Motte, L. (2013) · Nanoscale · doi:10.1039/c3nr03763k · Cited by 34
Pan, W., Han, C., Yue, L., Tai, L., Li, Z., Li, X., Xing, G., Yang, X., & Sun, L. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s43627 · Cited by 33
Egusquiaguirre, S. P., Manguán-García, C., Pintado‐Berninches, L., Iarriccio, L., Carbajo, D., Alberício, F., Royo, M., Pedraz, J. L., Hernández, R. M., Perona, R., et al. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.01.028 · Cited by 33
Xu, J., & Amiji, M. M. (2012) · Journal of Visualized Experiments · doi:10.3791/3612 · Cited by 32
Wang, X., Wang, Q., Li, J., An, S., Chen, Y., & Jiang, C. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s84930 · Cited by 32
Cancerious Cells Targeting and Destruction Using Folate Conjugated Gold Nanoparticles
Shakeri‐Zadeh, A., Mansoori, G. A., Hashemian, R., Eshghi, H., Sazgarnia, A., & Montazerabadi, A. (2010) · Cited by 32
RGD modified albumin nanospheres for tumour vasculature targeting
Dubey, P. K., Singodia, D., Verma, R. K., & Vyas, S. P. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01180.x · Cited by 30
Yang, Y., Yang, Y., Xie, X., Yang, Y., Yang, Y., Zhang, H., & Mei, X. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24333 · Cited by 29
Carbohydrate‐based Biomedical Copolymers for Targeted Delivery of Anticancer Drugs
David, A. (2010) · Israel Journal of Chemistry · doi:10.1002/ijch.201000021 · Cited by 27
Yang, Y., Jiang, Y., Wang, Z., Liu, J., Lü, Y., Ye, J., & Huang, Y. (2012) · Journal of Materials Chemistry · doi:10.1039/c2jm00121g · Cited by 23
Folate decorated magnetite nanoparticles: Synthesis and targeted therapy against ovarian cancer
Fazilati, M. (2013) · Cell Biology International · doi:10.1002/cbin.10167 · Cited by 22
Zhao, C., Liu, X., Liu, J., Yang, Z., Rong, X., Li, M., Liang, X., & Wu, Y. F. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.10.024 · Cited by 20
Wu, W., Huang, C.-M., & Liao, P.-W. (2014) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2014.05.003 · Cited by 20
Self‐assembled penetratin‐deferasirox micelles as potential carriers for hydrophobic drug delivery
Goswami, D., Vitorino, H. A., Machini, M. T., & Espósito, B. P. (2015) · Biopolymers · doi:10.1002/bip.22672 · Cited by 18
Qi, H., Li, Z., Du, K., Mu, K., Zhou, Q., Liang, S., Zhu, W., Yang, X., & Zhu, Y. (2014) · Nanoscale Research Letters · doi:10.1186/1556-276x-9-595 · Cited by 18
Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses
Zappavigna, S., Misso, G., Falanga, A., Perillo, E., Novellino, E., Galdiero, M., Grieco, P., Caraglia, M., & Galdiero, S. (2016) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201017666160415155145 · Cited by 17
Synthesis of Apolipoprotein B Lipoparticles to Deliver Hydrophobic/Amphiphilic Materials
Chu, H., Cheng, T.-M., Chen, H., Chou, F.-H., Chang, Y., Lin, H., Liu, S.-Y., Liang, Y., Hsu, M.-H., Wu, D.-S., et al. (2013) · ACS Applied Materials & Interfaces · doi:10.1021/am401808e · Cited by 16
Rudolph, C., & Rosenecker, J. (2012) · Cold Spring Harbor Protocols · doi:10.1101/pdb.prot068122 · Cited by 12
In vivo compatibility and degradation of crosslinked gelatin gels incorporated in knitted Dacron
(2000) · Pure Amsterdam UMC · doi:10.1002/(sici)1097-4636(200007)51:1 · Cited by 4
Cited by
Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
Yao, Y., Zhou, Y., Liu, L., Xu, Y., Chen, Q., Wang, Y., Wu, S., Deng, Y., Zhang, J., & Shao, A. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00193 · Cited by 1,451
Gold Nanoparticles in Diagnostics and Therapeutics for Human Cancer
Singh, P., Pandit, S., Mokkapati, V. R. S. S., Garg, A., Ravikumar, V., & Mijakovic, I. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071979 · Cited by 1,038
Nanomedicine in cancer therapy
Fan, D., Cao, Y., Cao, M., Wang, Y., Cao, Y., & Gong, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01536-y · Cited by 878
Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies
Marques, A. C., Costa, P. J., Velho, S., & Amaral, M. H. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.035 · Cited by 349
Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies
Mahvi, D. A., Liu, R., Grinstaff, M. W., Colson, Y. L., & Raut, C. P. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21498 · Cited by 338
Metadata
- Authors
- Bahrami, B., Hojjat-Farsangi, M., Mohammadi, H., Anvari, E., Ghalamfarsa, G., Yousefi, M., & Jadidi-Niaragh, F.
- Venue
- Immunology Letters
- Publisher
- Elsevier BV
- Published
- 2017-10
- Volume
- 190
- Pages
- 64-83
- ISSN
- 0165-2478 (ISSN-L)
- OpenAlex
- W2741312435
- Cited by
- 510
- References
- 303
- FWCI
- 15.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.